Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
Hims & Hers' “Sick of the System” spot not only generated the highest engagement of all pharma-related ads that aired during ...
Hims & Hers' future growth is expected from personalized solutions, with potential to expand the subscriber base by millions.
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
By contrast, Novo Nordisk is both the developer and seller of Wegovy, while Viking Therapeutics's VK2735 has posted impressive results in testing and is now in the later stages of development. Wegovy ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results